Welcome

United States Drug Delivery Technology Markets

 

  • Research Code : 5726-01-00-00-00
  • SKU : HC00251-NA-MR_03241
  • Share this :
  • Release Date : 22-Mar-1999
  • Region : North America
  • Request Study Sample

Availability: In stock

 
USD 2,450

* Required Fields

Pay By Invoice

Be the first to review this product



Table of Contents

United States Drug Delivery Technology Markets, Executive Summary

Introduction to Drug Delivery Technologies

Objectives and Purpose
Report Scope and Segmentation
Report Structure

Summary of Major Findings

Total Revenues and Revenue Growth Rates
Percent Revenues by Product Type
Percent Revenues by Disease Category
Analysis by Major Segment
Competitive Analysis

United States Drug Delivery Technology Markets, Market Engineering Research Methodology

Frost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare Industry

Frost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare Industry

Research Sources

Secondary Sources
Primary Research

Industry Specific Forecast Model

Industry Specific Forecast Model
Population-Based Forecast
Product-Based Forecast
Market Model Assumptions

Presentation of Market Engineering Measurements, Definition and their Strategic Significance

Presentation of Market Engineering Measurements, Definition and their Strategic Significance

United States Drug Delivery Technology Markets, Challenges in the Drug Delivery Technologies Market

Identification of Challenges Facing the Drug Delivery Technologies Market

Identification of Challenges Facing the Drug Delivery Technologies Market
Competing with Well Known DrugDelivery Companies to Gain Profitable Corporate Collaborations
Expanding Beyond a Drug Delivery Company to Full Integration with Limited Revenues
Maintaining High Profit Margins in Increasingly Generic Markets
Developing Systems Which Do Not Impinge on Patents
Discovering Novel Therapeutic Areas Which Can Be Addressed by Technologies
Effectively Marketing Systems with Limited Advantages

United States Drug Delivery Technology Markets, Overview of the Drug Delivery Companies

Introduction

Introduction
Company Profiles

Market Engineering Research for the Oral Drug Delivery Technologies Market

Market Overview and Definitions

Overview
Technology Overview

Market Engineering Research Measurement System

Market Engineering Research Measurement System

Market Drivers

Market Drivers
Growth in the Discovery of "Biotechnology" Compounds Increases Development of Drug Delivery Products
The Drive to Obviate Revenue Loss from Patent Expiration Motivates Alignment with Drug Delivery Companies
Pliability of Delivery Systems Creates Significant Market Opportunities
Beneficial Safety and Efficacy Profiles Drive Penetration of Delivery Products
Price Premium Charged for Products Drives Gross Revenues
Improvements in Technology Decreases Development and Manufacture Cost of some Systems.

Market Restraints

Market Restraints
Generic Competition Diminishes Manufacturer Revenues and Decreases the value of Key Markets
Financial Barriers to Entry Remain Obstacles for Less Established Competitors
Patent Infringement Limits Market Opportunities
Collaborative Partnerships Prevent Greater Revenue Realization by Drug Delivery Manufacturers

Market Engineering Revenue Forecasts (1996-2002)

Total Revenues
Breakout of Revenues by Disease Category

Research and Development

Research and Development
Actiq
Ditropan XL

Competitive Environment

Competitive Structure
Market Share Analysis
Market Share Participants

Products Analysis

Products Analysis
Alkermes, Inc.
Alza Corporation
Andrx Corporation
Anesta Corporation
Biovail Corporation
Elan Corporation
Fuisz Technologies
Genta, Inc.

Market Engineering for the Transdermal Drug Delivery Technologies Market

Market Overview and Definitions

Overview
Technology Overview

Market Drivers

Market Drivers
The Emergence of Combination Patches for Female Hormone Replacement Therapy Drive Long-Term Growth
Potential to Extend Product LinesMotivates Formation of Profitable Partnerships
Advantages Drives Penetration of Transdermal Products into Key Markets
Second Generation Androgen Patches Highlight Disease and Positively Effect Market Revenues
Implementation of New Technology has Potential to Drive Market in the Long Term

Market Restraints

Market Restraints
Technological Limitations Inhibit Reach of Transdermal Delivery Systems
Generic Competition Diminishes Manufacturer Revenues and Decreases the Value of Key Markets
Minimal Advantages May Inhibit Greater Product Penetration
Collaborative Partnerships Prevent Greater Revenue Realization by Drug Delivery Manufacturers

Market Engineering Research Measurement System

Market Engineering Research Measurement System

Market Engineering Revenue Forecasts (1996-2002)

Total Revenues
Breakout of Revenues by Disease Category

Research and Development

Research and Development
Combination Patches for Hormone Replacement Therapy
Extended Release Ritalin

Competitive Environment

Competitive Structure
Market Share Analysis
Market Share Participants

Product Analysis

Product Analysis
Alza Corporation
Becton Dickinson
Cellegy Pharmaceuticals
Cygnus, Inc.
Elan Pharmaceutical Technologies
Iomed, Inc.
MacroChem Corporation
Noven Pharmaceuticals

Market Engineering Research for the Inhale Drug Delivery Technologies Market

Market Overview and Definitions

Overview
Technology Overview

Market Engineering Research Measurement System

Market Engineering Research Measurement System

Market Drivers

Market Drivers
Growth in the Discovery of "Biotechnology" Compounds Increases Development of Drug Delivery Products
Pliability of Delivery Systems Creates Significant Market Opportunities
The Drive to Generate Revenue Through Line Extensions Creates Profitable Partnerships for Drug Delivery Companies
Advantages of Inhale Delivery Systems Expected to Aid Future Penetration into Key Markets
Ability to Deliver Locally and Systemically Increases Market Opportunity

Market Restraints

Market Restraints
Unproved Technology Remains Challenge to Market Participants
Launch of Products Utilizing New Technology not Expected in Short-term
Manufacturing Costs Decrease Product Profit Margins
Collaborative Partnerships Prevent Greater Revenue Realization by Drug Delivery Manufacturers

Research and Development

Research and Development
Pain Management
Diabetes

Competitive Environment

Competitive Structure

Product Analysis

Product Analysis
Aradigm Corporation
Dura Pharmaceuticals
Inhale Therapeutics

Market Engineering Research for the Inject Drug Delivery Technologies Market

Market Overview and Definitions

Overview
Technology Overview

Market Engineering Research Measurement System

Market Engineering Research Measurement System

Market Drivers

Market Drivers
Potential to Extend Product Lines Motivates Formation of Profitable Partnerships
Beneficial Safety and Efficacy Profiles Drive Penetration of Delivery Products
Limited Competition Increases Market Opportunity
Growth in the Discovery of "Biotechnology" Compounds Increases Development of Drug Delivery Products
Price Premium Charged for Products Drives Gross Revenues

Market Restraints

Market Restraints
Limited Therapeutic Markets for Which Technology Is Applicable
Saturated Competitive Environmentin the Cancer Therapeutics Creates Fragmented Market
Infancy of Development Pipeline Negatively Impacts Total Market

Market Engineering Revenue Forecasts (1996-2002)

Total Revenues
Breakout of Revenues by Disease Category

Research and Development

Research and Development
Pegylated Intron A
Evacet

Competitive Environment

Competitive Structure
Market Share Analysis
Market Share Participants

Product Analysis

Product Analysis
Alkermes, Inc.
DepoTech
Enzon, Inc. (PEG-Modification System)
Epic Therapeutics
The Liposome Company
Sequus Pharmaceuticals, Inc.

United States Drug Delivery Technology Markets, Market Engineering Strategy

Market Engineering Strategic Recommendations

Market Engineering Strategic Recommendations
Strategies Based on Competitive Corporate Positioning
Strategies Based on Research and Development


Sample Study






Related Research
WHY CHOOSE
FROST & SULLIVAN
RESEARCH ?

1. Primary Research

Our analysis is based on comprehensive primary research conducted with core market participants.

2. Global Coverage

Unparalleled coverage of geographies, our analyst & consultant teams are based in 42+ offices spanning the globe.

3. Breadth of Vertical Industries

We cover the broadest spectrum of markets to provide our clients with the most relevant analysis and transformational insights.

4. Visionary Innovation Research

With on-going transformational shifts, our visionary innovation research prepares you with information on key megatrends shaping the future of your industry.

5. Mega Trends

Mega Trends are global forces that transform business, societies and economies.

6. Convergence Research Coverage

Taking an approach of analysing a macro-to-micro impact, our convergence research helps you prepare against an impending 'Kodak moment'.